Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms DOI Open Access
Rais Pavlov, Sergey A. Akimov, Э. Б. Дашинимаев

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13540 - 13540

Published: Dec. 18, 2024

Gene transfection is a fundamental technique in the fields of biological research and therapeutic innovation. Due to their biocompatibility membrane-mimetic properties, lipid vectors serve as essential tools transfection. The successful delivery genetic material into cytoplasm contingent upon fusion vector cellular membranes, which enables hydrophilic polynucleic acids traverse hydrophobic barriers two intervening membranes. This review examines critical role membrane lipofection efficiency, with particular focus on molecular mechanisms that govern lipoplex–membrane interactions. analysis will examine key challenges inherent process, from achieving initial proximity facilitating final content release through remodeling. In contrast viral vectors, utilize specialized proteins, necessitate strategic formulation environmental optimization enhance fusogenicity. discusses recent advances design fusion-promoting strategies, emphasizing potential improve gene yield. It highlights importance understanding for developing next-generation systems emphasizes need continued advance lipid-mediated technology.

Language: Английский

Engineered macrophage-derived cellular vesicles for NIR-II fluorescence imaging-guided precise cancer photo-immunotherapy DOI

Quanshi Lin,

Yichao Wang,

Linlin Wang

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 235, P. 113770 - 113770

Published: Feb. 1, 2024

Language: Английский

Citations

17

Biomimetic Trypsin-Responsive Structure-Bridged Mesoporous Organosilica Nanomedicine for Precise Treatment of Acute Pancreatitis DOI
Yanan Wang,

Deyao Qian,

Xinyuan Wang

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: 18(29), P. 19283 - 19302

Published: July 11, 2024

Developing strategies to target injured pancreatic acinar cells (PACs) in conjunction with primary pathophysiology-specific pharmacological therapy presents a challenge the management of acute pancreatitis (AP). We designed and synthesized trypsin-cleavable organosilica precursor bridged by arginine-based amide bonds, leveraging trypsin's ability selectively identify guanidino groups on arginine via Asp189 at active S1 pocket cleave carboxy-terminal (C-terminal) bond catalytic triads. The precursors were incorporated into framework mesoporous silica nanoparticles (MSNs) for encapsulating membrane-permeable Ca

Language: Английский

Citations

10

Mesenchymal Stem Cells‐Derived Extracellular Vesicles Mimetics as Osteoinductive Mediators for Bone Healing DOI Creative Commons
Antoine Karoichan, Ling Li, Celine J. Agnes

et al.

Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 21, 2025

Abstract Bone defects remain challenging to treat, with common therapies still relying on invasive approaches. Mesenchymal stem cell‐derived extracellular vesicles (MSC‐EVs) offer a promising alternative due their regenerative and immunomodulatory properties, but challenges in scalable EV production limit clinical translation. Nanoghosts (NGs) are an emerging class of EV‐mimetics synthesized through the physical distortion ghost cells that innate bioactivity similar EVs while having more yields. In this study, osteogenic potential NGs made from MSC ghosts (MSC‐NGs) is explored for first time contrasted conventional MSC‐EVs. MSC‐NGs generated sonication, yielding two‐fold compared MSC‐EVs same number cells. Unlike MSC‐EVs, significantly enhanced differentiation MSCs, evidenced by increased alkaline phosphatase (ALP) activity early mineralization. Proteomic analysis further revealed enriched osteogenesis‐related proteins than vivo, treatment 0.5 mm mouse femoral osteotomy accelerated fracture healing, showing callus mineralization day 14 improved bone marrow reconstitution 21, along reduced osteoclastic activity. These findings demonstrate as effective therapeutics tissue engineering, offering advantages over future healing strategies.

Language: Английский

Citations

1

Cryo-Trojan Mesenchymal Stem Cells as Non-Living Tumor-Homing Supercarriers for Enhanced Drug Delivery and Immune Activation in Prostate Cancer DOI Creative Commons

Chengran Wang,

Xianfang Rong,

Fuqiang Zhang

et al.

Materials Today Bio, Journal Year: 2025, Volume and Issue: 32, P. 101650 - 101650

Published: March 12, 2025

Prostate cancer remains a leading cause of cancer-related mortality, with conventional therapies limited by systemic toxicity and poor tumor targeting. Developing innovative drug delivery systems that enhance therapeutic specificity while minimizing off-target effects is critical. We engineered cryo-trojan human umbilical cord mesenchymal stem cells (CT-MSCs) as non-living, tumor-homing carriers for mitoxantrone (MTX), termed CT-MTX. Cryo-treatment preserved structural integrity chemokine receptors (CXCR4/CCR2) targeting eliminating proliferative risks. Comprehensive evaluations included loading/release kinetics, in vitro suppression, immunogenic cell death (ICD) induction, vivo efficacy/safety prostate models. CT-MTX demonstrated superior loading (116.38 μg/106 cells) pH-sensitive release (74.10 % at pH 5.5), outperforming exosomes, liposomes, living MSCs stability tumor-specific delivery. Compared to liposomes (low targeting) nanomaterials (biocompatibility concerns), leveraged MSC-derived tropism without tumorigenic In vitro, inhibited proliferation (84.83 MTX uptake), migration (4.42 residual migration), induced apoptosis (43.23 late apoptosis). Mechanistically, triggered ICD via PAMPs release, activating CD8+ T suppressing immunosuppressive Treg. vivo, selectively accumulated tumors, reducing growth 87.88 extending survival (93.30 vs. 66.70 controls) negligible toxicity. Proteomics revealed enriched immune pathways like NK cytotoxicity, validating its dual role direct killing activation. represents novel, non-proliferative platform combines the capacity enhanced safety controlled inducing ICDs other immunologically "cold" tumors improve infiltration.

Language: Английский

Citations

1

Cell Membrane Camouflaged Biomimetic Nanoparticles as a Versatile Platform for Brain Diseases Treatment DOI
Shiyu Wang, Longfei Yang,

Wenya He

et al.

Small Methods, Journal Year: 2024, Volume and Issue: unknown

Published: March 10, 2024

Abstract Although there are various advancements in biomedical the past few decades, still challenges treatment of brain diseases. The main difficulties inability to deliver a therapeutic dose drug through blood‐brain barrier (BBB) and serious side effects drug. Thus, it is essential select biocompatible carriers novel tools better enhance effect disease treatment. In recent years, biomimetic nanoparticles (BNPs) based on natural cell membranes, which have excellent biocompatibility low immunogenicity, widely used diseases enable successfully cross BBB target lesions. BNPs can prolong circulation time vivo, more conducive aggregation Cell membranes (CMs) from cancer cells (CCs), red blood (RBCs), white (WBCs), so as coatings for (NPs) achieve ability target, evade clearance, or stimulate immune system. This review summarizes application different sources discusses possibilities clinical translation.

Language: Английский

Citations

7

Plant-Derived Exosome-Like Nanovesicles-Created injectable hydrogel for augmented cancer immunotherapy DOI
Liting Yang, Di Zhang,

Dailin Lu

et al.

Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 491, P. 152032 - 152032

Published: May 7, 2024

Language: Английский

Citations

7

Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspective DOI Creative Commons
Antoine Karoichan,

Sarah Boucenna,

Maryam Tabrizian

et al.

Journal of Extracellular Vesicles, Journal Year: 2024, Volume and Issue: 13(7)

Published: June 28, 2024

Abstract Extracellular vesicles have gained wide momentum as potential therapeutics for osteoarthritis, a highly prevalent chronic disease that still lacks an approved treatment. The membrane‐bound are secreted by all cells carrying different cargos can serve both biomarkers and modifiers. Nonetheless, despite significant peak in research regarding EVs OA therapeutics, clinical implementation seems distant. In addition to scalability standardization challenges, researchers often omit focus on consider the proper tropism of vesicles, practicality relevance their source, low native therapeutic efficacy, whether they address whole. These considerations necessary better understand light been comprehensively discussed ultimately summarized this review into conceptualized framework termed nanodiamond concept. Future perspectives also discussed, alternatives presented some challenges concerns.

Language: Английский

Citations

6

Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere DOI

Yun-Fei Dong,

Yao-Sheng Li, Hui Liu

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 371, P. 484 - 497

Published: June 11, 2024

Language: Английский

Citations

5

Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease DOI Creative Commons
Tong Lei, Caifeng Li, Yang Liu

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: June 25, 2024

Abstract Parkinson’s disease (PD) is the second largest group of neurodegenerative diseases, and its existing drug treatments are not satisfactory. Natural cell membrane drugs used for homologous targeting to enhance efficacy. In this study, microfluidic electroporation chip prepared mesenchymal stem cell-derived neuron-like membrane-coated curcumin PLGA nanoparticles (MM-Cur-NPs) was synthesized explored therapeutic effect mechanism in PD. MM-Cur-NPs can protect neuron from damage, restore mitochondrial potential reduce oxidative stress vitro. PD mice, it also improve movement disorders damaged TH neurons. found be distributed brain metabolized with a delay within 24 h. After 1 h administration, were variety neurotransmitters significantly upregulated, such as dopamine. Differentially expressed genes RNA-seq enriched inflammation regulation, up-expression anti-inflammatory factors inhibited pro-inflammatory Mechanically, only neuronal apoptosis, inhibit microglial marker IBA-1 inflammation, but upregulate expression protein VDAC1 potential. This study proposes strategy provide neuroprotective effects through therapy

Language: Английский

Citations

5

From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges DOI Creative Commons
Wei Du, Xinyue Wang,

Yuyan Zhou

et al.

Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)

Published: Jan. 29, 2025

Acute pancreatitis (AP) is a disease characterized by an acute inflammatory response in the pancreas. This caused abnormal activation of pancreatic enzymes variety etiologic factors, which results localized response. The symptoms this include abdominal pain, nausea and vomiting fever. These are induced hyperinflammatory oxidative stress. In recent years, research has focused on developing anti-inflammatory antioxidative therapies for treatment (AP). However, there still limitations to approach, including poor drug stability, low bioavailability short half-life. advent nanotechnology opened up novel avenue management Nanomaterials can serve as efficacious vehicle conventional pharmaceuticals, enhancing their targeting ability, improving prolonging Moreover, they also exert direct therapeutic effect. review begins introducing general situation It then discusses pathogenesis current status treatment. Finally, it considers literature related nanomaterials. objective study provide comprehensive existing use nanomaterials particular, changes markers outcomes following administration examined. done with intention offering insights that inform subsequent facilitate clinical application

Language: Английский

Citations

0